A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. (Q43763423)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. |
scientific article |
Statements
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis (English)
Richard J Barohn
Miriam Freimer
Vern C Juel
Tahseen Mozaffar
Michelle L Mellion
Michael G Benatar
Maria Elena Farrugia
Jing Jing Wang
Suneil S Malhotra
John T Kissel
MG Study Group
30 April 2013